
Advancing Oncology Care: Understanding Alpelisib-Induced Hyperglycemia in PIK3CA+ Breast Cancer Patients
Aligning with the theme of SMA’s 117th Annual Scientific Assembly—Advancing Oncology Care and Prevention—the February issue of the SMA's peer-reviewed Southern Medical Journal features a timely review, "Alpelisib-Induced Hyperglycemia in PIK3CA+ Breast Cancer Patients".
This article highlights the incidence and risk factors of alpelisib-induced hyperglycemia in greater depth, offering valuable insights for oncology care providers. To support continued learning and discussion, SMA is making this article available to both members and non-members for a limited time. Click here to read the full article.
Stay connected as we explore critical advancements in oncology leading up to SMA’s 2025 Annual Scientific Assembly in New Orleans, November 13-15!